(Q34534087)

2 August 2017

1 reference

title

Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer (English)

1 reference

2 August 2017

1 reference

Lissbrant IF

1

1 reference

2 August 2017

Lissbrant E

series ordinal

2

1 reference

2 August 2017

Damber JE

series ordinal

3

1 reference

2 August 2017

Bergh A

series ordinal

4

1 reference

2 August 2017

publication date

1 December 2001

1 reference

Scandinavian Journal of Urology and Nephrology

2 August 2017

published in

1 reference

2 August 2017

volume

35

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

437-452

1 reference

Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis in urological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Advances in angiogenesis research: relevance to urological oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis in urological malignancy: prognostic indicator and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Tumor angiogenesis: past, present and the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Anticancer drug targets: approaching angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Circulating endothelial precursors: mystery, reality, and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis: new insights and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

VPF/VEGF and the angiogenic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Blood vessel maturation: vascular development comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Antiangiogenic therapy of transgenic mice impairs de novo tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

New perspectives in clinical oncology from angiogenesis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Role of vascular endothelial growth factor in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Molecular and biological properties of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Factors promoting tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Importance of angiogenesis in reproductive physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Manipulating angiogenesis. From basic science to the bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Defective angiogenesis in mice lacking endoglin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

The rationale and future potential of angiogenesis inhibitors in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenic factors as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

In vivo monitoring of tumor angiogenesis with MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Is angiogenesis inhibition the Holy Grail of cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Antiangiogenic tumour therapy: will it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Prostatic intraepithelial neoplasia in dogs with spontaneous prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

PIN I-III: when should we interfere?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Immunohistochemical Localization of the Androgen Receptor in Rat and Human Tissues*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Expression of vascular endothelial growth factor receptors in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

The application of an anti-angiogenic gene (thrombospondin-1) in the treatment of human prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Antiangiogenic activity of prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F003655901753367532

10.1080/003655901753367532

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference